Search Results - "Elshof, Lotte E."
-
1
Cause-specific Mortality in a Population-based Cohort of 9799 Women Treated for Ductal Carcinoma In Situ
Published in Annals of surgery (01-05-2018)“…OBJECTIVE:To assess cause-specific mortality in women treated for ductal carcinoma in situ (DCIS). BACKGROUND:From screening and treatment perspective, it is…”
Get full text
Journal Article -
2
Feasibility of a prospective, randomised, open-label, international multicentre, phase III, non-inferiority trial to assess the safety of active surveillance for low risk ductal carcinoma in situ – The LORD study
Published in European journal of cancer (1990) (01-08-2015)“…Abstract Background The current debate on overdiagnosis and overtreatment of screen-detected ductal carcinoma in situ (DCIS) urges the need for prospective…”
Get full text
Journal Article -
3
Finding the balance between over- and under-treatment of ductal carcinoma in situ (DCIS)
Published in Breast (Edinburgh) (01-02-2017)“…Abstract With the widespread adoption of population-based breast cancer screening, ductal carcinoma in situ (DCIS) has come to represent 20–25% of all breast…”
Get full text
Journal Article -
4
Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Published in Breast cancer research and treatment (01-10-2016)“…Purpose To assess the effect of different treatment strategies on the risk of subsequent invasive breast cancer (IBC) in women diagnosed with ductal carcinoma…”
Get full text
Journal Article -
5
Clinicopathological Risk Factors for an Invasive Breast Cancer Recurrence after Ductal Carcinoma In Situ -A Nested Case-Control Study
Published in Clinical cancer research (01-08-2018)“…Ductal carcinoma (DCIS) is treated to prevent progression to invasive breast cancer. Yet, most lesions will never progress, implying that overtreatment exists…”
Get full text
Journal Article -
6
Long-term risk of subsequent ipsilateral lesions after surgery with or without radiotherapy for ductal carcinoma in situ of the breast
Published in British journal of cancer (09-11-2021)“…Background Radiotherapy (RT) following breast-conserving surgery (BCS) for ductal carcinoma in situ (DCIS) reduces ipsilateral breast event rates in clinical…”
Get full text
Journal Article -
7
Discordant Marker Expression Between Invasive Breast Carcinoma and Corresponding Synchronous and Preceding DCIS
Published in The American journal of surgical pathology (01-11-2019)“…Ductal carcinoma in situ (DCIS) is considered a potential precursor of invasive breast carcinoma (IBC). Studies aiming to find markers involved in DCIS…”
Get full text
Journal Article -
8
The method of detection of ductal carcinoma in situ has no therapeutic implications: results of a population-based cohort study
Published in Breast cancer research : BCR (09-03-2017)“…Population screening with mammography has resulted in increased detection of ductal carcinoma in situ (DCIS). The aim of this population-based cohort study was…”
Get full text
Journal Article -
9
Erratum to: Subsequent risk of ipsilateral and contralateral invasive breast cancer after treatment for ductal carcinoma in situ: incidence and the effect of radiotherapy in a population-based cohort of 10,090 women
Published in Breast cancer research and treatment (2017)Get full text
Journal Article -
10
A practical approach to manage additional lesions at preoperative breast MRI in patients eligible for breast conserving therapy: results
Published in Breast cancer research and treatment (01-12-2010)“…The aim of this prospective study was to evaluate the efficacy of directives, established to handle additional lesions at preoperative contrast-enhanced…”
Get full text
Journal Article -
11
Does the pretreatment tumor sampling location correspond with metabolic activity on 18F-FDG PET/CT in breast cancer patients scheduled for neoadjuvant chemotherapy?
Published in European journal of radiology (01-12-2013)“…Abstract Purpose To define the correlation between the core biopsy location and the area with highest metabolic activity on 18F-FDG PET/CT in stage II–III…”
Get full text
Journal Article -
12
Abstract OT3-6-01: The LORD trial: A randomized, non-inferiority trial, between active surveillance versus standard treatment in patients with low risk ductal carcinoma in situ
Published in Cancer research (Chicago, Ill.) (01-05-2015)“…Abstract Background The goal in treating patients with ductal carcinoma in situ (DCIS) is to prevent the development of invasive breast cancer (iBC). However,…”
Get full text
Journal Article -
13
Ductal carcinoma in situ: the balance between over- and undertreatment
Published in Nederlands tijdschrift voor geneeskunde (2016)“…Since population-based breast cancer screening was implemented in the Netherlands, the incidence of Ductal Carcinoma In Situ of the breast, regarded as a…”
Get more information
Journal Article